Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
LLY:USNew York

Eli Lilly & Co

COMPANY INFO
189.64USD
+0.39+0.21%
Market Closed
As of 08:04 PM EDT 04/19/2021 EDT
Open
189.24
Prev Close
189.25
Volume
2,966,439
Market Cap
181.863B
Day Range
188.07190.88
52 Week Range
129.21218.00
1D1M1Y5Y
View Full Chart
Market Closed
As of 08:04 PM EDT 04/19/2021 EDT
1D1M1Y5Y
View Full Chart
News
Press Releases
business
Eli Lilly, BCG, Atlassian Execs on Leadership, Employee Mental Health
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio25.00
PEGY Ratio--
Shares Outstanding958.99M
Price to Book Ratio32.1554
Price to Sales Ratio7.0251
1 Year Return22.49%
30 Day Avg Volume3,713,856
EPS7.59
Dividend1.79%
Last Dividend Reported0.85
Earnings Announcement for Period Ending Q1/2021:04/27/2021

Compare
1-Day Performance

-1%0+1%
-1%0+1%
Equity
LLY:US
+0.21%
Sponsored By

About Eli Lilly & Co

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
Address
Lilly Corporate Center Indianapolis, IN 46285 United States
Phone
1-317-276-2000
Website
www.lilly.com

Income Statement

Quarterly
Annual
;
Q4 2020 (Millions USD)
  • Revenue
    7,440.00
  • Net Income
    2,116.80
  • Profit Margin
    28.45%

Balance Sheet

Quarterly
Annual
Q4 2020 (Millions USD)
  • Total Assets
    46,633,100,000.00
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Q4 2020 (Millions USD)
  • Operating
    1,815.20
  • Investing
    -674.10
  • Financing
    -1,079.30
Skip the following list of ads